Doca

NDA 1104, held by Organon USA Inc. Desoxycorticosterone Acetate.

As of Nov 14, 2026, NDA 1104 (Doca), held by Organon USA Inc, was first approved by FDA on Aug 17, 1939, with 1 approved supplement and 0 published complete response letters.

First approved: Aug 17, 1939
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Aug 17, 1939	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Doca5MG/ML · injectable;injection	Desoxycorticosterone Acetate	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Dec 5, 1986	Supplement 1Manufacturing	Approved	None posted
Aug 17, 1939	Original application	Approved	None posted

Identifiers

Application: NDA 1104
Drugs@FDA: Overview at FDA
Company: Organon USA

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters